Roble Belko & Company’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1
Closed 473
2026
Q1
$0 Hold
1
﹤0.01% 486
2025
Q4
$0 Hold
1
﹤0.01% 497
2025
Q3
$0 Hold
1
﹤0.01% 469
2025
Q2
$0 Buy
+1
New +$123 ﹤0.01% 455
2024
Q3
Sell
-1,405
Closed -$137K 375
2024
Q2
$137K Hold
1,405
0.02% 118
2024
Q1
$132K Hold
1,405
0.02% 122
2023
Q4
$131K Hold
1,405
0.02% 111
2023
Q3
$115K Sell
1,405
-48
-3% -$4.17K 0.02% 113
2023
Q2
$124K Hold
1,453
0.02% 107
2023
Q1
$128K Hold
1,453
0.03% 117
2022
Q4
$124K Hold
1,453
0.03% 118
2022
Q3
$115K Buy
1,453
+1,405
+2,927% +$118K 0.03% 116
2022
Q2
$4K Hold
48
﹤0.01% 274
2022
Q1
$4K Buy
+48
New +$4.63K ﹤0.01% 328

Other funds holding MS

Roble Belko & Company's MS Position: Q2 2026 in Review

Roble Belko & Company sold out of Morgan Stanley (MS) in Q2 2026, closing a stake of 1 share.

Roble Belko & Company first reported a position in MS in Q1 2022 and held it in 14 quarters. The position peaked at $137K in Q2 2024. 2,730 funds tracked by Wall St. Rank hold MS as of Q2 2026.

  • Roble Belko & Company reported no remaining Morgan Stanley position as of Q2 2026 after selling out during the quarter.
  • Roble Belko & Company sold 1 Morgan Stanley share in Q2 2026.
  • Roble Belko & Company first reported a position in Morgan Stanley in Q1 2022 and held it in 14 quarters.
  • Roble Belko & Company's Morgan Stanley position peaked at $137K in Q2 2024.
  • 2,730 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.